WO2006014726A3 - Immunoglobulines comprenant principalement une glycoforme man5glcnac2 - Google Patents
Immunoglobulines comprenant principalement une glycoforme man5glcnac2 Download PDFInfo
- Publication number
- WO2006014726A3 WO2006014726A3 PCT/US2005/025731 US2005025731W WO2006014726A3 WO 2006014726 A3 WO2006014726 A3 WO 2006014726A3 US 2005025731 W US2005025731 W US 2005025731W WO 2006014726 A3 WO2006014726 A3 WO 2006014726A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycoform
- immunoglobulins
- predominantly
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005269713A AU2005269713A1 (en) | 2004-07-21 | 2005-07-19 | Immunoglobulins comprising predominantly a Man5GlcNac2 glycoform |
CA002573554A CA2573554A1 (fr) | 2004-07-21 | 2005-07-19 | Immunoglobulines comprenant principalement une glycoforme man<sb>5</sb>glcnac<sb>2</sb> |
JP2007522696A JP2008507535A (ja) | 2004-07-21 | 2005-07-19 | 主にman5glcnac2グリコフォームを含むイムノグロブリン |
EP05790364A EP1771478A2 (fr) | 2004-07-21 | 2005-07-19 | Immunoglobulines comprenant principalement une glycoforme man5glcnac2 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58997904P | 2004-07-21 | 2004-07-21 | |
US58992604P | 2004-07-21 | 2004-07-21 | |
US60/589,979 | 2004-07-21 | ||
US60/589,926 | 2004-07-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006014726A2 WO2006014726A2 (fr) | 2006-02-09 |
WO2006014726A3 true WO2006014726A3 (fr) | 2006-07-20 |
Family
ID=35506030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/025731 WO2006014726A2 (fr) | 2004-07-21 | 2005-07-19 | Immunoglobulines comprenant principalement une glycoforme man5glcnac2 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1771478A2 (fr) |
JP (1) | JP2008507535A (fr) |
AU (1) | AU2005269713A1 (fr) |
CA (1) | CA2573554A1 (fr) |
WO (1) | WO2006014726A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877462B2 (en) | 2000-06-28 | 2014-11-04 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
US8986949B2 (en) | 2003-02-20 | 2015-03-24 | Glycofi, Inc. | Endomannosidases in the modification of glycoproteins in eukaryotes |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008063776A2 (fr) | 2006-10-12 | 2008-05-29 | Genentech, Inc. | Anticorps de la lymphotoxine-alpha |
WO2010075249A2 (fr) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | Méthode de traitement de la polyarthrite rhumatoïde avec des antagonistes de cellules b |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1211310A1 (fr) * | 1999-08-19 | 2002-06-05 | Kirin Beer Kabushiki Kaisha | Nouvelles variantes de levure et procede de production de glycoproteine |
WO2004074499A2 (fr) * | 2003-02-20 | 2004-09-02 | Gerngross Tillman U | Banques adn combinatoires destinees a produire des n-glycanes modifies dans des eucaryotes inferieurs |
EP1505149A1 (fr) * | 2002-04-26 | 2005-02-09 | Kirin Beer Kabushiki Kaisha | Methylotrophe produisant une chaine de sucre de type mammifere |
-
2005
- 2005-07-19 WO PCT/US2005/025731 patent/WO2006014726A2/fr active Application Filing
- 2005-07-19 AU AU2005269713A patent/AU2005269713A1/en not_active Abandoned
- 2005-07-19 CA CA002573554A patent/CA2573554A1/fr not_active Abandoned
- 2005-07-19 EP EP05790364A patent/EP1771478A2/fr not_active Withdrawn
- 2005-07-19 JP JP2007522696A patent/JP2008507535A/ja not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1211310A1 (fr) * | 1999-08-19 | 2002-06-05 | Kirin Beer Kabushiki Kaisha | Nouvelles variantes de levure et procede de production de glycoproteine |
EP1505149A1 (fr) * | 2002-04-26 | 2005-02-09 | Kirin Beer Kabushiki Kaisha | Methylotrophe produisant une chaine de sucre de type mammifere |
WO2004074499A2 (fr) * | 2003-02-20 | 2004-09-02 | Gerngross Tillman U | Banques adn combinatoires destinees a produire des n-glycanes modifies dans des eucaryotes inferieurs |
Non-Patent Citations (3)
Title |
---|
CHIBA YASUNORI ET AL: "Production of human compatible high mannose-type (Man5GlcNAc2) sugar chains in Saccharomyces cerevisiae", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 273, no. 41, 9 October 1998 (1998-10-09), pages 26298 - 26304, XP002202331, ISSN: 0021-9258 * |
CHOI B-K ET AL: "Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 100, no. 9, 29 April 2003 (2003-04-29), pages 5022 - 5027, XP002267831, ISSN: 0027-8424 * |
SHINKAWA T ET AL: "The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 278, no. 5, 31 January 2003 (2003-01-31), pages 3466 - 3473, XP002965857, ISSN: 0021-9258 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877462B2 (en) | 2000-06-28 | 2014-11-04 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
US8883483B2 (en) | 2000-06-28 | 2014-11-11 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
US8986949B2 (en) | 2003-02-20 | 2015-03-24 | Glycofi, Inc. | Endomannosidases in the modification of glycoproteins in eukaryotes |
Also Published As
Publication number | Publication date |
---|---|
JP2008507535A (ja) | 2008-03-13 |
EP1771478A2 (fr) | 2007-04-11 |
CA2573554A1 (fr) | 2006-02-09 |
WO2006014726A2 (fr) | 2006-02-09 |
AU2005269713A1 (en) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006071856A3 (fr) | Immunoglobulines comprenant principalement une glycoforme man5glcnac2 | |
WO2006014683A3 (fr) | Immunoglobulines contenant principalement une glycoforme gal2glcnac2man3glcnac2 | |
WO2006066568A3 (fr) | Anticorps | |
WO2007147122A3 (fr) | Anticorps monoclonaux qui reconnaissent sélectivement des composés de méthamphétamine et de type méthamphétamine | |
WO2008091798A3 (fr) | Anticorps de ca9 optimises et methodes d'utilisation associees | |
WO2006094192A3 (fr) | Anticorps humanises l243 | |
WO2007129895A3 (fr) | Anticorps monoclonal antagoniste anti-cd40 humain | |
WO2006104989A3 (fr) | Anticorps a regions fc modifiees et utilisations | |
WO2006020114A3 (fr) | Regions fc de variants | |
WO2007050569A3 (fr) | Films de polypeptide multicouches et procedes | |
WO2003102066A3 (fr) | Dispersions aqueuses d'adhesif | |
MY150621A (en) | Anti-epha2 antibody | |
WO2002075274A3 (fr) | Methode et trousse pour le suivi des maladies neurodegeneratives | |
WO2006119056A3 (fr) | Vehicule supersonique plus leger que l'air | |
WO2007063415A3 (fr) | Procedes de production de lymphocytes b stables | |
WO2005067848A3 (fr) | Procede de collage de surfaces sur une bande | |
WO2006014726A3 (fr) | Immunoglobulines comprenant principalement une glycoforme man5glcnac2 | |
EP1344827A3 (fr) | Protéines antigel de basidiomycètes | |
WO2005035490A3 (fr) | Procede de synthese de d-tocotrienols | |
WO2004075021A3 (fr) | Procedes de modelisation moleculaire | |
FR2855557B1 (fr) | Volet de tuyere a duree de vie augmentee pour turbomoteurs d'avion. | |
NL1021490A1 (nl) | Werkwijze voor de bereiding van een fluorpolymeer. | |
WO2007036501A3 (fr) | Copolymere greffe et son utilisation | |
WO2005057042A3 (fr) | Materiau de friction | |
ITTO20021050A1 (it) | Struttura di carenatura di un veicolo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2573554 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005790364 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007522696 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005269713 Country of ref document: AU Ref document number: 200580024712.6 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1209/DELNP/2007 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2005269713 Country of ref document: AU Date of ref document: 20050719 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005269713 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005790364 Country of ref document: EP |